Multiple myeloma (MM) is a chronic hematological malignancy associated with substantial morbidity and healthcare utilization. We conducted a retrospective population-based study using the Spanish Minimum Basic Data Set to analyze MM-related hospitalizations in Spain. All hospitalizations with a diagnosis of MM during the study period were included. Demographic characteristics, comorbidities, complications, and outcomes were assessed, and temporal trends were evaluated using quasi-Poisson regression models. A total of 107,496 hospitalizations involving 43,383 unique patients were analyzed. Hospitalization rates increased significantly over the study period, from 25.1 to 34.6 per 100,000 population (p < 0.001). Median patient age at hospitalization was 73 years, and 47% were women. In-hospital mortality was 11%, decreasing from 13% in 2016 to 9.6% in 2023 despite an increasing comorbidity burden. Mortality increased with age, and marked regional variability was observed. These findings indicate a growing healthcare burden but improved survival, likely reflecting advances in MM treatment and supportive care.
No takes yet. Share an insight, caveat, or question.
López et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: